Praxis Fuer Dermatologie Und Venerologie — Clinical Trial Site

12 Registered trials

5 Currently recruiting

Organisation

Praxis Fuer Dermatologie Und Venerologie

Location

Dresden, Germany

Identifier

ORG-100032765

Address

Hauptstrasse 36a, Innere Neustadt, 01097, Germany

Departments

2202: Dermatologie
Dermatology
Hauarztpraxis Dr. Gerlach
Hautarztpraxis Dr. Beatrice Gerlach
N/A
NA
Practice for dermatology
Praxis fuer Dermatologie Und Venerologie
Praxis fur Dermatologie and Venerologie
Praxis für Dermatologie und Venerologie

Clinical trials at this site (12)

Search interface

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the E… Recruiting

2023-505121-14-00 Moderate to Severe Plaque Psoriasis 5 2024-01-18
Long-Term Safety Study of Deucravacitinib versus Ustekinumab in Participants with Psoriasis (PRAGMATYK) Recruiting

2023-503766-24-00 Moderate to Severe Plaque Psoriasis 11 2026-05-26
Platform study to evaluate the efficacy and safety of investigational compound(s) in patients with moderate to severe atopic dermatitis Recruiting

2024-519081-49-00 Moderate to severe atopic dermatitis 4 2025-10-28
A 16-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g Compared to a Dummy Cream in Adult Subjects With Mild t… Recruiting

2024-518856-21-00 Mild to severe palmoplantar pustulosis 4 2025-08-28
Evaluation of the efficacy and safety of a new gel containing 10 mg/g Clindamycin and 0.25 mg/g Tretinoin vs. the originator Acnatac(R) 10 m… Recruiting

2023-504552-10-01 Papulopustular acne 5 2024-05-14
A Phase 3, Multicenter, Open-Label Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of TAK-279 in Subjects with Moderate-t… Ended

2024-512496-12-00 Moderate to Severe Plaque Psoriasis 5 2025-04-01
A Phase 3 Placebo-Controlled Study With Randomized Dose Up/Dose Down Extension Period Investigating the Efficacy, Safety, and Tolerability o… Ended

2022-502518-98-00 nonsegmental vitiligo 5 2024-04-26
Long-term study to assess the safety and efficacy of Nemolizumab in subjects with Atopic Dermatitis Ended

2024-514404-13-00 Atopic Dermatitis 5 2020-10-01
A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 With a Randomized Withdrawal and Retreatment Period in Subject… Ended

2023-505842-24-00 Moderate to Severe Plaque Psoriasis 5 2024-05-07
Clinical study to compare the therapeutic effects of two ointments with active substances betamethasone dipropionate and salicylic acid and … Ended

2024-514788-24-00 Chronic stable plaque psoriasis 5 2022-09-20
Clinical study to compare two cutaneous ointments with the active substance methylprednisolone aceponate 0.1% and one cutaneous ointment wit… Ended

2024-514548-10-01 Mild to moderate atopic dermatitis 3 2021-07-26
An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Sev… Ended

2022-502361-15-00 Moderate-to-Severe Plaque Psoriasis 5 2019-12-12